07:14 AM EDT, 08/07/2025 (MT Newswires) -- Zimmer Biomet ( ZBH ) reported Q2 adjusted earnings Thursday of $2.07 per diluted share, up from $2.01 a year earlier.

Analysts surveyed by FactSet expected $1.98.

Net sales for the quarter ended June 30 were $2.08 billion, up from $1.94 billion a year earlier.

Analysts polled by FactSet expected $2.06 billion.

The company said it now expects 2025 adjusted diluted EPS of $8.10 to $8.30, up from the previous outlook of $7.90 to $8.10. Analysts surveyed by FactSet expect $7.97.

Zimmer Biomet ( ZBH ) narrowed its 2025 revenue growth outlook to a range of 6.7% to 7.7%, compared with the prior range of 5.7% to 8.2%.

The company's shares were up more than 1% in recent premarket activity Thursday.